Literature DB >> 3423751

Palindromic rheumatism. A clinical survey of sixty patients.

P Hannonen1, T Möttönen, M Oka.   

Abstract

Sixty patients with palindromic rheumatism (PR) with a total follow-up time of 598 years and 295 years prospectively are presented. The study shows that PR is not a rare condition, but the syndrome is often ignored or misdiagnosed by the physician. Most cases of PR appear to evolve into chronic arthritis. PR may precede other kinds of systemic diseases, such as SLE, Wegener's granulomatosis, and multiple myeloma. The presence of PR in patients with fibromyalgia is reported in this paper. Gold appears to be the best drug for the treatment of PR. Cases of fibromyalgia and PR are treated successfully with antimalarial drugs. Our proposed diagnostic criteria for PR are as follows: 1) recurrent attacks of sudden-onset mono or polyarthritis or of periarticular tissue inflammation, lasting from a few hours to one week; 2) verification of at least one attack by a physician; 3) subsequent attacks in at least three different joints; 4) exclusion of other forms of arthritides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3423751     DOI: 10.3109/03009748709165412

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  13 in total

1.  Palindromic rheumatism: different genetic background implies a distinct disease entity.

Authors:  S-K Kim; H-S Lee; K W Lee; S-C Bae; J-B Jun
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

2.  Antiphospholipid syndrome and palindromic rheumatism: a new possible association.

Authors:  Tatiana Reitblat; Irena Litinsky; Dan Caspi; Ori Elkayam
Journal:  Rheumatol Int       Date:  2004-07-23       Impact factor: 2.631

3.  Palindromic rheumatism in Israel--a disease entity? A survey of 34 patients.

Authors:  A Eliakim; L Neumann; J Horowitz; D Buskila; A Kleiner-Baumgarten; S Sukenik
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

4.  Efficacy of rituximab in resistant palindromic rheumatism: first report in literature.

Authors:  Padmaja Raghavan; Sreelakshmi Sreenath; Somy Cherian; Padmanabha D Shenoy
Journal:  Clin Rheumatol       Date:  2019-05-10       Impact factor: 2.980

5.  In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up.

Authors:  Yasser Emad; Ashraf Anbar; Ihab Abo-Elyoun; Nashwa El-Shaarawy; Hadeel Al-Hanafi; Hatem Darwish; Mona Gamil; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2014-03-13       Impact factor: 2.980

6.  The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.

Authors:  Yumi Tani; Takayuki Kishi; Takako Miyamae; Manabu Kawamoto; Yasushi Kawaguchi; Atsuo Taniguchi; Hisashi Yamanaka
Journal:  Clin Rheumatol       Date:  2020-01-02       Impact factor: 2.980

Review 7.  Palindromic rheumatism as part of the rheumatoid arthritis continuum.

Authors:  Kulveer Mankia; Paul Emery
Journal:  Nat Rev Rheumatol       Date:  2019-10-08       Impact factor: 20.543

8.  Efficacy of musculoskeletal injections given by primary care providers in the office.

Authors:  Tasnim Eghbal Eftekhaari; Mirzaali Nazarnezhad; Iman Ghasemzadeh
Journal:  Int J Gen Med       Date:  2013-09-16

9.  Association between periodontitis and the risk of palindromic rheumatism: A nationwide, population-based, case-control study.

Authors:  Ching-Heng Lin; Der-Yuan Chen; Wen-Cheng Chao; Tsai-Ling Liao; Yi-Ming Chen; Hsin-Hua Chen
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

10.  Is palindromic rheumatism amongst children a benign disease?

Authors:  Yonatan Butbul-Aviel; Yosef Uziel; Nofar Hezkelo; Riva Brik; Gil Amarilyo
Journal:  Pediatr Rheumatol Online J       Date:  2018-02-13       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.